Fig. 5From: Third dose mRNA vaccination against SARS-CoV-2 reduces medical complaints seen in primary care: a matched cohort studyMedical complaints related to COVID-19 for individuals less than 45Â years. Lines show the cumulative incidence of visiting the general practitioner or emergency ward with common complaints suspected to be related to COVID-19 (with R992) for up to 90Â days after a (hypothetical) date of the third dose of mRNA vaccines, per 100,000 individuals for individuals under the age of 45. Red curve shows individuals with three doses (three-dose group), and blue curve shows the control group consisting of individuals without three doses. Shaded areas show 95% confidence intervals. Competing risk includes death and hospitalization for the six outcomes, but the cumulative incidence of competing risks was not plotted to ensure the clarity and readability of the graphBack to article page